Role of p38 and p44/42 mitogen-activated protein kinases in microglia

GLIA

Volumn 40, Issue 2, 2002, Pages 175-183

  Koistinaho, Milla ^a   Koistinaho, Jari ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Alzheimer's disease; Brain ischemia; Cytokines; Inflammation

Indexed keywords

LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL; BRAIN INJURY; CEREBROVASCULAR ACCIDENT; DEGENERATIVE DISEASE; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; HUMAN; METABOLISM; MICROGLIA; PHYSIOLOGY; REVIEW;

ANIMALS; BRAIN INJURIES; CEREBROVASCULAR ACCIDENT; ENZYME ACTIVATION; HUMANS; LIPOPOLYSACCHARIDES; MICROGLIA; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NEURODEGENERATIVE DISEASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 0036847840     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.10151     Document Type: Review

References (109)

1. Adams JP, Sweatt JD. 2002. Molecular psychology: Roles for the ERK MAP Kinase cascade in memory. Annu Rev Pharmacol Toxicol 42:135-163.
2. Aikawa R, Komuro I, Yamazaki T, Zou Y, Kudoh S, Tanaka M, Shiojima I, Hiroi Y, Yazaki Y. 1997. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J Clin Invest 100:1813-1821.
3. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T. 2000. Inflammation and Alzheimer's disease. Neurobiol Aging 21:383-421.
4. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270:27489-27494.
5. Atzori C, Ghetti B, Piva R, Srinivasan AN, Zolo P, Delisle MB, Mirra SS, Migheli A. 2001. Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis. J Neuropathol Exp Neurol 60:1190-1197.
6. Bhat NR, Zhang P, Lee JC, Hogan EL. 1998. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 18:1633-1641.
7. Boulton TG, Cobb MH. 1991. Identification of multiple extracellular signal-regulated kinases (ERKs) with antipeptide antibodies. Cell Regul 2:357-371.
8. Boulton TG, Yancopoulos GD, Gregory JS, Slaughter C, Moomaw C, Hsu J, Cobb MH. 1990. An insulin-stimulated protein kinase similar to yeast kinases involved in cell cycle control. Science 249:64-67.
9. Boulton TG, Gregory JS, Cobb MH. 1991. Purification and properties of extracellular signal-regulated kinase 1, an insulin-stimulated microtubule-associated protein 2 kinase. Biochemistry 30:278-286.
10. Bruce-Keller AJ, Keeling JL, Keller JN, Huang FF, Camondola S, Mattson MP. 2000. Antiinflammatory effects of estrogen on microglial activation. Endocrinology 141:3646-3656.
11. Chen RH, Sarnecki C, Blenis J. 1992. Nuclear localization and regulation of erk- and rsk-encoded protein kinases. Mol Cell Biol 12:915-927.
12. Choi DW. 1992. Bench to bedside: The glutamate connection. Science 258:241-243.
13. Choi DW. 1988. Glutamate neurotoxicity and diseases of the nervous system. Neuron 623-634.
14. Cobb MH, Goldsmith EJ. 1995. How MAP kinases are regulated. J Biol Chem 270:14843-14846.
15. Cobb MH, Boulton TG, Robbins DJ. 1991. Extracellular signal-regulated kinases: ERKs in progress. Cell Regul 2:965-978.
16. Combs CK, Johnson DE, Cannady SB, Lehman TM, Landreth GE. 1999. Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of betaamyloid and prion proteins. J Neurosci 19:928-939.
17. Combs CK, Karlo JC, Kao SC, Landreth GE. 2001. beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci 21:1179-1188.
18. Crews CM, Alessandrini A, Erikson RL. 1992. The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science 258:478-480.
19. Cuenda A, Alonso G, Morrice N, Jones M, Meier R, Cohen P, Nebreda AR. 1996. Purification and cDNA cloning of SAPKK3, the major activator of RK/p38 in stress- and cytokine-stimulated monocytes and epithelial cells. EMBO J 15:4156-4164.
20. Cuenda A, Cohen P, Buee-Scherrer V, Goedert M. 1997. Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J 16:295-305.
21. Da Silva J, Pierrat B, Mary JL, Lesslauer W. 1997. Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J Biol Chem 272:28373-28380.
22. D'Aversa TG, Weidenheim KM, Berman JW. 2002. CD40-CD40L interactions induce chemokine expression by human microglia: Implications for human immunodeficiency virus encephalitis and multiple sclerosis. Am J Pathol 160:559-567.
23. Davies CA, Loddick SA, Stroemer RP, Hunt J, Rothwell NJ. 1998. An integrated analysis of the progression of cell responses induced by permanent focal middle cerebral artery occlusion in the rat. Exp Neurol 154:199-212.
24. Davies CA, Loddick SA, Toulmond S, Stroemer RP, Hunt J, Rothwell NJ. 1999. The progression and topographic distribution of interleukin-1beta expression after permanent middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 19:87-98.
25. Deak M, Clifton AD, Lucocq LM, Alessi DR. 1998. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J 17:4426-4441.
26. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A 92:7686-7689.
27. Fabrizi C, Silei V, Menegazzi M, Salmona M, Bugiani O, Tagliavini F, Suzuki H, Lauro GM. 2001. The stimulation of inducible nitricoxide synthase by the prion protein fragment 106-126 in human microglia is tumor necrosis factor-alpha-dependent and involves p38 mitogen-activated protein kinase. J Biol Chem 276:25692-25696.
28. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273:18623-18632.
29. Ferrer I, Blanco R, Carmona M. 2001. Differential expression of active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates following quinolinic acid excitotoxicity in the rat. Brain Res Mol Brain Res 94:48-58.
30. Fiore RS, Murphy TH, Sanghera JS, Pelech SL, Baraban JM. 1993. Activation of p42 mitogen-activated protein kinase by glutamate receptor stimulation in rat primary cortical cultures. J Neurochem 61:1626-1633.
31. Freshney NW, Rawlinson L, Guesdon F, Jones E, Cowley S, Hsuan J, Saklatvala J. 1994 Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 78:1039-1049.
32. Frodin M, Gammeltoft S. 1999. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocrinol 151:65-77.
33. Fukunaga R, Hunter T. 1997. MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J 16:1921-1933.
34. Gonzalez FA, Seth A, Raden DL, Bowman DS, Fay FS, Davis RJ. 1993. Serum-induced translocation of mitogen-activated protein kinase to the cell surface ruffling membrane and the nucleus. J Cell Biol 122:1089-1101
35. Guan Z, Buckman SY, Pentland AP, Templeton DJ, Morrison AR. 1998. Induction of cyclooxygenase-2 by the activated MEKK1→SEK1/MKK4→p38 mitogen-activated protein kinase pathway. J Biol Chem 273:12901-12908.
36. Hale KK, Trollinger D, Rihanek M, Manthey CL. 1999. Differential expression and activation of p38 mitogen-activated protein kinase alpha, beta, gamma, and delta in inflammatory cell lineages. J Immunol 162:4246-4252.
37. Halliday G, Robinson SR, Shepherd C, Kril J. 2000. Alzheimer's disease and inflammation: A review of cellular and therapeutic mechanisms. Clin Exp Pharmacol Physiol 27:1-8.
38. Hanisch UK, Prinz M, Angstwurm K, Hausler KG, Kann O, Kettenmann H, Weber JR. 2001. The protein tyrosine kinase inhibitor AG126 prevents the massive microglial cytokine induction by pneumococcal cell walls. Eur J Immunol 31:2104-2115.
39. Hanks SK, Hunter T. 1995. Protein kinases 6. The eukaryotic protein kinase superfamily: Kinase (catalytic) domain structure and classification. FASEB J 9:576-596.
40. Hasegawa H, Nakai M, Tanimukai S, Taniguchi T, Terashima A, Kawamata T, Fukunaga K, Miyamoto E, Misaki K, Mukai H, Tanaka C. 2001. Microglial signaling by amyloid beta protein through mitogen-activated protein kinase mediating phosphorylation of MARCKS. NeuroReport 12:2567-2571.
41. Hensley K, Floyd RA, Zheng NY, Nael R, Robinson KA, Nguyen X, Pye QN, Stewart CA, Geddes J, Markesbery WR, Patel E, Johnson GV, Bing G. 1999 p38 kinase is activated in the Alzheimer's disease brain. J Neurochem 72:2053-2058.
42. Herlaar E, Brown Z. 1999. p38 MAPK signalling cascades in inflammatory disease. Mol Med Today 5:439-447.
43. Hide I, Tanaka M, Inoue A, Nakajima K, Kohsaka S, Inoue K, Nakata Y. 2000. Extracellular ATP triggers tumor necrosis factor-alpha release from rat microglia. J Neurochem 75:965-972.
44. Higgins LS, Holtzman DM, Rabin J, Mobley WC, Cordell B. 1994. Transgenic mouse brain histopathology resembles early Alzheimer's disease. Ann Neurol 35:598-607.
45. Higgins LS, Rodems JM, Catalano R, Quon D, Cordell B. 1995. Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for beta-APP751. Proc Natl Acad Sci USA 92:4402-4406.
46. Honda S, Nakajima K, Nakamura Y, Imai Y, Kohsaka S. 1999. Rat primary cultured microglia express glial cell line-derived neurotrophic factor receptors. Neurosci Lett 275:203-206.
47. Hsiao KM, Chou SY, Shih SJ, Ferrell JE Jr. 1994. Evidence that inactive p42 mitogen-activated protein kinase and inactive Rsk exist as a heterodimer in vivo. Proc Natl Acad Sci U S A 91:5480-5484.
48. Huot J, Houle F, Marceau F, Landry J. 1997. Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ Res 80:383-392.
49. Ip YT, Davis RJ. 1998. Signal transduction by the c-Jun N-terminal kinase (JNK) - From inflammation to development. Curr Opin Cell Biol 10:205-219.
50. Iqbal K, Grundke-Iqbal I. 1996. Molecular mechanism of Alzheimer's neurofibrillary degeneration and therapeutic intervention. Ann N Y Acad Sci 777:132-138.
51. Jiang Y, Chen C, Li Z, Guo W, Gegner JA, Lin S, Han J. 1996. Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta). J Biol Chem 271:17920-17926.
52. Kato Y, Kravchenko VV, Tapping RI, Han J, Ulevitch RJ, Lee JD. 1997. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J 16:7054-7066.
53. Koistinaho M, Ort M, Cimadevilla JM, Vondrous R, Cordell B, Koistinaho J, Bures J, Higgins LS. 2001. Specific spatial learning deficits become severe with age in beta-amyloid precursor protein transgenic mice that harbor diffuse beta-amyloid deposits but do not form plaques. Proc Natl Acad Sci U S A. 98:14675-14680.
54. Koistinaho M, Kettunen MI, Goldsteins G, Keinanen R, Salminen A, Ort M, Bures J, Liu D, Kauppinen RA, Higgins LS, Koistinaho J. 2002. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: Role of inflammation. Proc Natl Acad Sci U S A 99:1610-1615.
55. Kumar S, McDonnell PC, Gum RJ, Hand AT, Lee JC, Young PR. 1997. Novel homologues of CSBP/p38 MAP kinase: Activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun 23:533-538.
56. Kyriakis JM, Avruch J. 1996. Sounding the alarm: Protein kinase cascades activated by stress and inflammation. J Biol Chem 271:24313-24316.
57. Kyriakis JM, Avruch J. 2001. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81:807-869.
58. Lambert H, Charette SJ, Bernier AF, Guimond A, Landry J. 1999. HSP27 multimerization mediated by phosphorylation-sensitive intermolecular interactions at the amino terminus. J Biol Chem 274:9378-9385.
59. Lechner C, Zahalka MA, Giot JF, Moller NP, Ullrich A. 1996. ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. Proc Natl Acad Sci U S A 93:4355-4359.
60. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, Strickler SE, McLaughlin MM, Seimens I, Fisher S, Livi GP, White JR, Adams JL, Young PR. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739-746.
61. Lee YB, Schrader JW, Kim SU. 2000. p38 map kinase regulates TNF-alpha production in human astrocytes and microglia by multiple mechanisms. Cytokine 12:874-880.
62. Li Y, Liu L, Barger SW, Mrak RE, Griffin WS. 2001. Vitamin E suppression of microglial activation is neuroprotective. J Neurosci Res 66:163-170.
63. Liva SM, Kahn MA, Dopp JM, de Vellis J. 1999. Signal transduction pathways induced by GM-CSF in microglia: Significance in the control of proliferation. Glia 26:344-352.
64. Marais R, Wynne J, Treisman R. 1993. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73:381-393.
65. Marshall CJ. 1994. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr Opin Genet Dev 4:82-89.
66. Marshall CJ. 1995. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185.
67. McDonald DR, Bamberger ME, Combs CK, Landreth GE. 1998. beta-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. J Neurosci 18:4451-4460.
68. McGeer PL, McGeer EG. 1999. Inflammation of the brain in Alzheimer's disease: Implications for therapy. J Leukoc Biol 65:409-415.
69. McGeer PL, Schulzer M, McGeer EG. 1996. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies. Neurology 47:425-432.
70. Mielke K, Herdegen T. 2000. JNK and p38 stress kinases - Degenerative effectors of signal-transduction-cascades in the nervous system. Prog Neurobiol 61:45-60.
71. Miyazawa K, Mori A, Okudaira H. 1998. Regulation of interleukin-1beta-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by glucocorticoids. J Biochem (Tokyo) 124:1130-1137.
72. Moller T, Hanisch UK, Ransom BR. 2000. Thrombin-induced activation of cultured rodent microglia. J Neurochem 75:1539-1547.
73. Morioka T, Kalehua AN, Streit WJ. 1993. Characterization of microglial reaction after middle cerebral artery occlusion in rat brain. J Comp Neurol 327:123-132.
74. New L, Jiang Y, Zhao M, Liu K, Zhu W, Flood LJ, Kato Y, Parry GC, Han J. 1998. PRAK, a novel protein kinase regulated by the p38 MAP kinase. EMBO J 17:3372-3384.
75. Ono K, Han J. 2000. The p38 signal transduction pathway: Activation and function. Cell Signal 12:1-13.
76. Prinz M, Kann O, Draheim HJ, Schumann RR, Kettenmann H, Weber JR, Hanisch UK. 1999. Microglial activation by components of gram-positive and -negative bacteria: Distinct and common routes to the induction of ion channels and cytokines. J Neuropathol Exp Neurol 58:1078-1089.
77. Pyo H, Jou I, Jung S, Hong S, Joe EH. 1998. Mitogen-activated protein kinases activated by lipopolysaccharide and beta-amyloid in cultured rat microglia. NeuroReport 9:871-874.
78. Pyo H, Joe E, Jung S, Lee SH, Jou I. 1999. Gangliosides activate cultured rat brain microglia. J Biol Chem 274:34584-34589.
79. Quon D, Wang Y, Catalano R, Scardina JM, Murakami K, Cordell B. 1991. Formation of beta-amyloid protein deposits in brains of transgenic mice. Nature 352:239-241.
80. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, Davis RJ. 1995. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270:7420-7426.
81. Ridley SH, Sarsfield SJ, Lee JC, Bigg HF, Cawston TE, Taylor DJ, DeWitt DL, Saklatvala J. 1997. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: Regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J Immunol 158:3165-3173.
82. Ridley SH, Dean JL, Sarsfield SJ, Brook M, Clark AR, Saklatvala J. 1998. A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA. FEBS Lett 439:75-80.
83. Rosen LB, Ginty DD, Weber MJ, Greenberg ME. 1994. Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of Ras. Neuron 12:1207-1221.
84. Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D, Hunt T, Nebreda AR. 1994. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78:1027-1037.
85. Rupalla K, Allegrini PR, Sauer D, Wiessner C. 1998. Time course of microglia activation and apoptosis in various brain regions after permanent focal cerebral ischemia in mice. Acta Neuropathol (Berl) 96:172-178.
86. Ryu J, Pyo H, Jou I, Joe E. 2000. Thrombin induces NO release from cultured rat microglia via protein kinase C, mitogen-activated protein kinase, and NF-kappa B. J Biol Chem 275:29955-29959.
87. Saccani S, Pantano S, Natoli G. 2002. p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat Immunol 3:69-75.
88. Sanghera JS, Peter M, Nigg EA, Pelech SL. 1992. Immunological characterization of avian MAP kinases: Evidence for nuclear localization. Mol Biol Cell 3:775-787.
89. Schlapbach R, Spanaus KS, Malipiero U, Lens S, Tasinato A, Tschopp J, Fontana A. 2000. TGF-beta induces the expression of the FLICE-inhibitory protein and inhibits Fas-mediated apoptosis of microglia. Eur J Immunol 30:3680-3688.
90. Seth A, Gonzalez FA, Gupta S, Raden DL, Davis RJ. 1992. Signal transduction within the nucleus by mitogen-activated protein kinase. J Biol Chem 267:24796-24804.
91. Shigemoto-Mogami Y, Koizumi S, Tsuda M, Ohsawa K, Kohsaka S, Inoue K. 2001. Mechanisms underlying extracellular ATP-evoked interleukin-6 release in mouse microglial cell line, MG-5. J Neurochem 78:1339-1349.
92. Slevin M, Krupinski J, Slowik A, Rubio F, Szczudlik A, Gaffney J. 2000. Activation of MAP kinase (ERK-1/ERK-2), tyrosine kinase and VEGF in the human brain following acute ischaemic stroke. NeuroReport 11:2759-2764.
93. Smith JA, Poteet-Smith CE, Malarkey K, Sturgill TW. 1999. Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo. J Biol Chem 274:2893-2898.
94. Sugden PH, Clerk A. 1997. Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. Cell Signal 9:337-351.
95. Suo Z, Wu M, Ameenuddin S, Anderson HE, Zoloty JE, Citron BA, Andrade-Gordon P, Festoff BW. 2002. Participation of protease-activated receptor-1 in thrombin-induced microglial activation. J Neurochem 80:655-666.
96. Tan J, Town T, Saxe M, Paris D, Wu Y, Mullan M. 1999. Ligation of microglial CD40 results in p44/42 mitogen-activated protein kinase-dependent TNF-alpha production that is opposed by TGF-beta 1 and IL-10. J Immunol 163:6614-6621.
97. Tan J, Town T, Mori T, Wu Y, Saxe M, Crawford F, Mullan M. 2000a. CD45 opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase. J Neurosci 20:7587-7594.
98. Tan J, Town T, Mullan M. 2000b. CD45 inhibits CD40L-induced microglial activation via negative regulation of the Src/p44/42 MAPK pathway. J Biol Chem 275:37224-37231.
99. Tian D, Litvak V, Lev S. 2000. Cerebral ischemia and seizures induce tyrosine phosphorylation of PYK2 in neurons and microglial cells. J Neurosci 20:6478-6487.
100. Tikka TM, Koistinaho JE. 2001. Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol 166:7527-7533.
101. Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J. 2001. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21:2580-2588.
102. Tong L, Pav S, White DM, Rogers S, Crane KM, Cywin CL, Brown ML, Pargellis CA. 1997. A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket. Nat Struct Biol 4:311-316.
103. Walton KM, DiRocco R, Bartlett BA, Koury E, Marcy VR, Jarvis B, Schaefer EM, Bhat RV. 1998. Activation of p38MAPK in microglia after ischemia. J Neurochem 70:1764-1767.
104. Wang XS, Diener K, Manthey CL, Wang S, Rosenzweig B, Bray J, Delaney J, Cole CN, Chan-Hui PY, Mantlo N, Lichenstein HS, Zukowski M, Yao Z. 1997. Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase. J Biol Chem 272:23668-23674.
105. Waskiewicz AJ, Flynn A, Proud CG, Cooper JA. 1997. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J 16:1909-1920.
106. Waskiewicz AJ, Johnson JC, Penn B, Mahalingam M, Kimball SR, Cooper JA. 1999. Phosphorylation of the cap-binding protein eukaryotic translation initiation factor 4E by protein kinase Mnk1 in vivo. Mol Cell Biol 19:1871-1880.
107. Whitmarsh AJ, Shore P, Sharrocks AD, Davis RJ. 1995. Integration of MAP kinase signal transduction pathways at the serum response element. Science 269:403-407.
108. Wisniewski HM, Wegiel J. 1992. Alzheimer's disease neuropathology. Current status of interpretation of lesion development. Ann N Y Acad Sci 673:270-284.
109. 2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of MKK6 and p38. J Biol Chem 273:22681-22692.